simendan has been researched along with Pulmonary Disease, Chronic Obstructive in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dekhuijzen, PN; Heunks, LM; van Hees, HW | 1 |
| Abroug, F; Dachraoui, F; Dimassi, S; Mebazaa, A; Ouanes, I; Ouanes-Besbes, L | 1 |
2 other study(ies) available for simendan and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Levosimendan enhances force generation of diaphragm muscle from patients with chronic obstructive pulmonary disease.
Topics: Aged; Cardiotonic Agents; Comorbidity; Diaphragm; Dose-Response Relationship, Drug; Female; Humans; Hydrazones; In Vitro Techniques; Lung Neoplasms; Male; Middle Aged; Muscle Contraction; Muscle Proteins; Myosin Heavy Chains; Pulmonary Disease, Chronic Obstructive; Pyridazines; Simendan | 2009 |
Weaning difficult-to-wean chronic obstructive pulmonary disease patients: a pilot study comparing initial hemodynamic effects of levosimendan and dobutamine.
Topics: Aged; Aged, 80 and over; Cardiotonic Agents; Dobutamine; Female; Hemodynamics; Humans; Hydrazones; Male; Middle Aged; Pilot Projects; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Pulmonary Wedge Pressure; Pyridazines; Respiration; Respiration, Artificial; Simendan; Ventilator Weaning; Ventricular Dysfunction, Left | 2011 |